Illumina Ventures Revenue and Competitors
Estimated Revenue & Valuation
- Illumina Ventures's estimated annual revenue is currently $3.5M per year.
- Illumina Ventures's estimated revenue per employee is $152,174
Employee Data
- Illumina Ventures has 23 Employees.
- Illumina Ventures grew their employee count by 21% last year.
Illumina Ventures's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Financial Officer | Reveal Email/Phone |
2 | Venture Partner | Reveal Email/Phone |
3 | Principal | Reveal Email/Phone |
4 | Partner | Reveal Email/Phone |
5 | Founding Partner | Reveal Email/Phone |
6 | Venture Partner | Reveal Email/Phone |
Illumina Ventures Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $7.5M | 10 | -55% | N/A | N/A |
#2 | N/A | 35 | -3% | N/A | N/A |
#3 | $7.5M | 8 | -27% | N/A | N/A |
#4 | $3.5M | 79 | 52% | N/A | N/A |
#5 | N/A | 11 | 0% | N/A | N/A |
#6 | $7.5M | 29 | -12% | N/A | N/A |
#7 | $15M | 43 | -16% | N/A | N/A |
#8 | $15M | 34 | N/A | N/A | N/A |
#9 | $7.5M | 26 | 24% | N/A | N/A |
#10 | $15M | 245 | 18% | N/A | N/A |
What Is Illumina Ventures?
Illumina Ventures is an independently managed firm focused on early-stage companies that are pioneering new applications of genomics and enabling precision medicine. We invest in life science tools, clinical diagnostics, therapeutics, and other opportunities to improve human health. Our strategic relationship with Illumina provides us access to the expertise and vision of the world's leading genomics solutions provider. Our team members have decades of entrepreneurial experience in genomics and a passion for improving human health.
keywords:N/A
N/A
Total Funding
23
Number of Employees
$3.5M
Revenue (est)
21%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Illumina Ventures News
4) The $80m venture financing of Sherlock Biosciences by Catalio Capital Management,First Albany Capital,Good Ventures,Illumina Ventures...
Covid-19 derailed Illumina's (NASDAQ:ILMN) 2020 progress, ... Biotech IPOs have a good 2021 year, with current venture capitals exiting the...
Other Companies in San Francisco
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.1M | 23 | -8% | $33.9M |
#2 | $2.8M | 23 | 5% | N/A |
#3 | $4.8M | 23 | 10% | N/A |
#4 | $1.6M | 23 | N/A | N/A |
#5 | $2.3M | 23 | N/A | N/A |